Not all clients with CLL need therapy. Inspite of all modern improvements, the iwCLL nonetheless suggests watchful observation for individuals with asymptomatic disorder.86 This advice relies on not less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104